Jacob Bell - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Jacob Bell's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Jacob Bell
Verified
Reporter, BioPharma Dive
Frederick, Washington
Beats
Functional Neurological Disorder,Autism FND, illness Chronic Pain, Chronic Illness Family
Content
By Jacob Bell Verified| BioPharma Dive Verified The most effective drug for Parkinson’s disease hasn’t changed in 50 years. But fresh research published in one of the country’s top scientific journals is helping build the case for a more cutting-edge approach that uses stem cells to restore important brain functions. The second most common neurodegenerative illness, Parkinson’s, is caused by the loss of certain nerve cells. These cells produce a chemical messenger, dopamine, that plays a crucial role regulating movement.
By Jacob Bell Verified| Yahoo Verified This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. The most effective drug for Parkinson’s disease hasn’t changed in 50 years. But fresh research published in one of the country’s top scientific journals is helping build the case for a more cutting-edge approach that uses stem cells to restore important brain functions.
By Jacob Bell Verified| BioPharma Dive Verified The most effective drug for Parkinson’s disease hasn’t changed in 50 years. But fresh research published in one of the country’s top scientific journals is helping build the case for a more cutting-edge approach that uses stem cells to restore important brain functions. The second most common neurodegenerative illness, Parkinson’s, is caused by the loss of certain nerve cells. These cells produce a chemical messenger, dopamine, that plays a crucial role regulating movement.
Company Info
BioPharma Dive
Banking Dive is a prominent online publication dedicated to the banking industry. It offers in-depth journalism and analysis, providing valuable insights into the latest news, trends, and regulatory changes affecting the sector. As part of Industry Dive, which has merged with TechTarget's technology websites and Informa Tech, Banking Dive has expanded its editorial reach significantly. The platform features a variety of services, including detailed news coverage, a newsletter for subscribers, and deep dive articles that explore specific topics such as regulations and technology's role in banking. Banking Dive caters to professionals in the banking sector, including executives, policymakers, and financial analysts, delivering reliable information to help them navigate the evolving landscape of the industry.
Washington, District of Columbia, United States
+1 202-331-2480